uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA.ORCID-id: 0000-0002-1278-6245
Imperial Coll, Natl Heart & Lung Inst, London, England;Royal Brompton Hosp, London, England.
Stanford Univ, Dept Med, SCCR, Stanford, CA 94305 USA.
Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
Vise andre og tillknytning
2019 (engelsk)Inngår i: Clinical Cardiology, ISSN 0160-9289, E-ISSN 1932-8737, Vol. 42, nr 5, s. 498-505Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

In the setting of prior myocardial infarction, the oral antiplatelet ticagrelor added to aspirin reduced the risk of recurrent ischemic events, especially, in those with diabetes mellitus. Patients with stable coronary disease and diabetes are also at elevated risk and might benefit from dual antiplatelet therapy. The Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS, NCT01991795) is a Phase 3b randomized, double-blinded, placebo-controlled trial of ticagrelor vs placebo, on top of low dose aspirin. Patients >= 50 years with type 2 diabetes receiving anti-diabetic medications for at least 6 months with stable coronary artery disease as determined by a history of previous percutaneous coronary intervention, bypass grafting, or angiographic stenosis of >= 50% of at least one coronary artery were enrolled. Patients with known prior myocardial infarction (MI) or stroke were excluded. The primary efficacy endpoint is a composite of cardiovascular death, myocardial infarction, or stroke. The primary safety endpoint is Thrombolysis in Myocardial Infarction major bleeding. A total of 19 220 patients worldwide have been randomized and at least 1385 adjudicated primary efficacy endpoint events are expected to be available for analysis, with an expected average follow-up of 40 months (maximum 58 months). Most of the exposure is on a 60 mg twice daily dose, as the dose was lowered from 90 mg twice daily partway into the study. The results may revise the boundaries of efficacy for dual antiplatelet therapy and whether it has a role outside acute coronary syndromes, prior myocardial infarction, or percutaneous coronary intervention.

sted, utgiver, år, opplag, sider
2019. Vol. 42, nr 5, s. 498-505
Emneord [en]
antiplatelet therapy, clinical trials, diabetes mellitus, general clinical cardiology, adult, ischemic heart disease
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-387294DOI: 10.1002/clc.23164ISI: 000468080800001PubMedID: 30788847OAI: oai:DiVA.org:uu-387294DiVA, id: diva2:1329025
Forskningsfinansiär
AstraZenecaTilgjengelig fra: 2019-06-24 Laget: 2019-06-24 Sist oppdatert: 2019-06-24bibliografisk kontrollert

Open Access i DiVA

fulltext(1124 kB)104 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 1124 kBChecksum SHA-512
9f0fe7209e13601ddb72d5441b035a6d64953d0623defcd2d06dbe3846b59b873ab7fb08646c5fea9feed0b4b4de0e607f74e7cf9b615416acc9228ebcd5d0c2
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Held, ClaesHagström, EmilHolmgren, PernillaHallberg, TheresaRenlund Grausne, KarinAlm, CristinaMichelgård Palmquist, ÅsaSvanberg, Camilla

Søk i DiVA

Av forfatter/redaktør
Bhatt, Deepak L.Held, ClaesHagström, EmilHolmgren, PernillaHallberg, TheresaRenlund Grausne, KarinAlm, CristinaMichelgård Palmquist, ÅsaSvanberg, Camilla
Av organisasjonen
I samme tidsskrift
Clinical Cardiology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 104 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 30 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf